phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Value-based programs between biopharmaceutical companies and pharmacy benefit manager Express Scripts saved $4.3 billion on medicines last year. Patients in these plans with innovative contracting arrangements taking cholesterol-lowering medicines saved nearly $800,000 out of pocket. 

In these arrangements, biopharmaceutical companies agree to take on more risk and be reimbursed based on how well medicines work for patients. This can lead to lower copays and coinsurance for patients, allowing them to access the right treatments the first time.

VBC

In addition to out-of-pocket savings, patients also saw the benefits of improved care coordination from these innovative contracting arrangements, which included over 100 different medicines. For example, multiple sclerosis patients, for whom adherence is critical, had an average adherence rate of nearly 85% where an innovative contract was in place, compared to an average adherence rate of 25% among all individuals with MS. All Express Scripts plans that used innovative contracting arrangements saw better care and lower spending compared to plans without innovative contracting in every participating therapeutic class.  

This adds to growing evidence that innovative contracts can lower out-of-pocket costs and enable patients to access the right treatments the first time. To learn more, visit www.phrma.org/value-collaborative.

Katie Koziara

Katie Koziara is Senior Director of public affairs at PhRMA focusing on the organization’s executive visibility work and media relations strategy. She previously ran the social media strategy for a D.C.-based non-profit working on federal management and leadership issues. Katie earned her B.A. in Public Policy from the University of Michigan’s Ford School and is currently earning her M.A. in Fiction Writing from Johns Hopkins University.

Katie Koziara

Delivering breakthroughs and lower costs for patients

September 8, 2025

The hidden cost of 340B: A multi-billion-dollar burden on taxpayers and Medicaid

July 14, 2025

Ensuring access to affordable medicines for patients through Medicaid

April 28, 2025

Health care practitioners sound the alarm on middlemen-imposed barriers to patient care, need for policy change

March 13, 2025

"ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements"

Access

Out-of-Pocket Costs

Medicaid

The Value Collaborative

Lets Talk About Cost

ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements

April 20, 2020

"ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements"

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list